Parecoxib
- Product Name
- Parecoxib
- CAS No.
- 1709956-95-5
- Chemical Name
- Parecoxib
- Synonyms
- Parecoxib;ValdecoxibImpurity39;Parecoxib Impurity 33;Valdecoxib Impurity N;3-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonyl Chloride;Benzenesulfonyl chloride, 3-(5-methyl-3-phenyl-4-isoxazolyl)-
- CBNumber
- CB6951641
- Molecular Formula
- C16H12ClNO3S
- Formula Weight
- 333.79
- MOL File
- 1709956-95-5.mol
Parecoxib Property
- Melting point:
- 165-167°C
- Boiling point:
- 459.4±45.0 °C(Predicted)
- Density
- 1.340±0.06 g/cm3(Predicted)
- storage temp.
- Refrigerator
- solubility
- DMSO (Slightly), Methanol (Slightly)
- pka
- -3.44±0.50(Predicted)
- form
- Solid
- color
- White to Off-White
N-Bromosuccinimide Price
- Product number
- M305725
- Product name
- 3-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonylChloride
- Packaging
- 1mg
- Price
- $165
- Updated
- 2021/12/16
- Product number
- 462055
- Product name
- Parecoxib
- Packaging
- 10mg
- Price
- $305
- Updated
- 2021/12/16
Parecoxib Chemical Properties,Usage,Production
Uses
Anti-inflammatory; analgesic (cyclooxygenase COX-2 inhibitor).
Uses
3-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonyl Chloride is an Impurity of Parecoxib Sodium (P193275), an anti-inflammatory, analgesic.
Clinical Use
Parecoxib is a pro-drug of valdecoxib administered IM or IV for perioperative analgesic and anti-inflammatory use. As a pro-drug, it undergoes rapid in vivo hydrolysis to valdecoxib.Parecoxib at greater than 20 mg has analgesic activity superior to that of placebo and similar to that of parenteral 30 or 60 mg of ketorolac in patients with postoperative dental pain. A significant adverse effect is drug hypersensitivity. Parecoxib is currently marketed worldwide but has not been approved for use in the United States.
Synthesis
The acylation of 4-(5-methyl- 3-phenylisoxazol-4-yl)benzenesulfonamide (valdecoxib), with propionic anhydride in a solution of triethanolamine (TEA) and 4-dimethylaminophenol (DMAP) in tetrahydrofuran gives N-propionamide, which is treated with NaOH in ethanol to give the sodium salt of parecoxib .
Drug interactions
Potentially hazardous interactions with other drugs
ACE inhibitors and angiotensin-II antagonists:
antagonism of hypotensive effect; increased risk of
nephrotoxicity and hyperkalaemia.
Analgesics: avoid concomitant use of 2 or more
NSAIDs, including aspirin (increased side effects);
avoid with ketorolac (increased risk of side effects
and haemorrhage).
Antibacterials: possible increased risk of convulsions
with quinolones.
Anticoagulants: effects of coumarins and
phenindione enhanced; possibly increased risk of
bleeding with heparin, dabigatran and edoxaban.
Antidepressants: increased risk of bleeding with
SSRIs and venlafaxine.
Antidiabetics: possibly enhanced effect of
sulphonylureas.
Antiepileptics: possibly enhanced effect of phenytoin.
Antifungals: if used with fluconazole reduce the dose
of parecoxib.
Antivirals: increased risk of haematological toxicity
with zidovudine; concentration possibly increased by
ritonavir.
Ciclosporin: potential for increased risk of
nephrotoxicity.
Cytotoxics: reduced excretion of methotrexate,
(possible increased risk of toxicity); increased risk of
bleeding with erlotinib.
Diuretics: increased risk of nephrotoxicity; possible
antagonism of diuretic effect; increased risk of
hyperkalaemia with potassium-sparing diuretics.
Lithium: reduced excretion of lithium (risk of
toxicity).
Pentoxifylline: possibly increased risk of bleeding.
Tacrolimus: increased risk of nephrotoxicity.
Metabolism
Parecoxib is rapidly and almost completely converted to
valdecoxib and propionic acid.
Elimination of valdecoxib
is by extensive hepatic metabolism involving multiple
pathways, including cytochrome P 450 (CYP) 3A4 and
CYP2C9 isoenzymes and glucuronidation (about 20%) of
the sulphonamide moiety.
Excretion is mainly via the urine with about 70% of a dose
appearing as inactive metabolites. No unchanged parecoxib is
found in the urine with only trace amounts in the faeces.
Parecoxib Preparation Products And Raw materials
Raw materials
Preparation Products
Parecoxib Suppliers
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 14059
- Advantage
- 65
- Tel
- 0755-4000505016 13380397412
- Fax
- 0755 28094224
- 3001272453@qq.com
- Country
- China
- ProdList
- 4969
- Advantage
- 50
- Tel
- 021-64609169 18901607656
- Fax
- 021-64609160
- greensnown@163.com
- Country
- China
- ProdList
- 9911
- Advantage
- 50
- Tel
- 15374522761
- Fax
- QQ:2853117752
- 3003392093@qq.com
- Country
- China
- ProdList
- 7891
- Advantage
- 55
- Tel
- +86-400-002-6226 13028896684
- sales@rrkchem.com
- Country
- China
- ProdList
- 55894
- Advantage
- 58
- Tel
- 17825480238
- Fax
- QQ 3008233717
- 3008233717@qq.com
- Country
- China
- ProdList
- 9844
- Advantage
- 12
- Tel
- 86-714-3992388
- overseasales1@yongstandards.com
- Country
- United States
- ProdList
- 14336
- Advantage
- 58
- Tel
- 2710913286@.com
- 1513643261@qq.com
- Country
- China
- ProdList
- 14253
- Advantage
- 58
- Tel
- 400-820-6829
- sales@mitachieve.com
- Country
- China
- ProdList
- 8864
- Advantage
- 58
- Tel
- 0755-0755-0755-83725350 13380397412
- Fax
- 0755-28094224
- 3001280422@qq.com
- Country
- China
- ProdList
- 9942
- Advantage
- 58